Health ministry recommends remdesivir for moderate cases, HCQ for early course of COVID-19

Under emergency use authorization, remdesivir may be considered for patients in moderate stage requiring oxygen support. It is not recommended for those with severe renal impairment and high level of liver enzymes, pregnant and lactating women, and those below 12 years, the document stated.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3hoJnLo
via IFTTT